In vivo Assessment of Brain Microstructure in Patients with Huntington's Disease Using Quantitative MRI
This study demonstrates that quantitative multiparametric MRI (MPM) effectively detects stage-specific microstructural alterations, such as early demyelination in premanifest and widespread neuronal loss in manifest Huntington's disease, establishing MPM as a valuable non-invasive biomarker for tracking neurodegeneration and correlating with clinical severity.